FDA Classified Major Tomato Recall Now Classified as Deadly
While it is unlikely that the affected tomatoes will still be sitting on your countertops, the agency urges consumers to double-check their freezers for any tomatoes that may be stored there.
Gordon Food Service Stores initially sold the recalled tomatoes in numerous states, including New York, Illinois, Indiana, Michigan, Kentucky, Pennsylvania, Tennessee, Missouri, Wisconsin, and Mississippi. The affected products were packaged in clamshell containers with the UPC #7 96553 20062 1 and a master case label with Lot # RM250424 15250B or Lot # RM250427 15250B
The update to a Class I, the most severe type of FDA recall, affects packages sold in Georgia, North Carolina, and South Carolina under the name H&C Farms Label. These tomatoes came in various sizes, from 3-packs to 25-pound bags, and were sold between April 23 and April 28.
Salmonella is a potentially deadly infection that can cause symptoms such as diarrhea, nausea, vomiting, fever, and in rare cases, endocarditis, arthritis, and arterial infections. According to the CDC, roughly 420 people die from acute salmonellosis each year in the United States. The organization urges anyone with symptoms resembling Salmonella to consult their healthcare provider.
If you discover you have any of the affected tomatoes still in your possession, you should discard the product and avoid consuming it, per the recall.
You Might Also Like
Can Apple Cider Vinegar Lead to Weight Loss?
Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
28 minutes ago
- Medscape
EMA OKs Oral Treatment for Postnatal Depression
The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted a positive opinion on zuranolone (Zurzuvae, Biogen Netherlands BV), the first oral drug to treat postpartum depression in adults. Marketing authorization was granted in recognition of clinical trial results showing a reduction in postpartum depressive symptoms after 2 weeks' treatment. Zuranolone is a neuroactive steroid that enhances the activity of the neurotransmitter gamma-aminobutyric acid (GABA). It is thought to exert antidepressant effects by enhancing GABAergic inhibition. In a multicenter, randomized, double-blind, placebo-controlled study, zuranolone at a 50 mg dose was given for 14 days to women who met the Diagnostic and Statistical Manual of Mental Disorders criteria for a major depressive episode of postpartum depression and whose symptoms started in the third trimester or within 4 weeks of delivery. Compared with placebo, the active group demonstrated significantly greater symptom improvement on days 3,15 (the primary endpoint), and 45, using the standard 17-item Hamilton rating scale for depression. The FDA approved the drug in August 2023, at which time it was the first oral treatment for postpartum depression, with previous therapies requiring intravenous dosing. It is available in 20 mg, 25 mg, and 30 mg capsules. The most common side effects are somnolence, dizziness, confusion, trouble walking, and sedation. Patients are advised to avoid alcohol and not to drive, operate machinery, or undertake other dangerous activities until at least 12 hours after taking each dose during the 14-day treatment course. There may also be an increased risk of suicidal thoughts and actions in people 24 years of age and younger. Animal studies have suggested a possible risk of teratogenic effects, so women who may become pregnant are advised to use effective contraception during treatment and for 1 week after the final dose, and to alert their healthcare provider should they become pregnant during treatment. The EMA said that detailed recommendations will be described in the summary of product characteristics, which will be published on the EMA website in all official European Union languages after the marketing authorization has been granted by the European Commission. Perinatal Mental Healthcare 'in Its Infancy' In Western countries, postpartum depression is estimated to affect between 10% and 15% of women during the first year after birth , with substantial differences in rates depending on socioeconomic factors such as marital status, educational level, social support, spouse care, violence, gestational age, breast feeding, child mortality, financial difficulties, partnership, life stress, smoking, alcohol intake, and living conditions. Common symptoms include feelings of desperation, sadness, anxiety, irritability, and isolation, as well as nausea, changes in sleep and eating habits, decreased libido, crying spells, mental lability, thoughts of hurting oneself and/or the infant, and suicidal ideation. The condition can wreak havoc on women's mental health as well as that of their partners. It can impair the parental relationship, the mother-child bond, and the emotional and cognitive growth of infants, with potential long-term effects. Postnatal depression may occur alongside post-traumatic stress disorder following stressful or traumatic childbirth experiences . Yet a review published in Frontiers in Psychiatry last year suggested that fewer than half of countries in the World Health Organization (WHO) European region had policies specifically on perinatal mental health, leading its authors to conclude that "perinatal mental health care is in its infancy in most WHO European countries."
Yahoo
2 hours ago
- Yahoo
VCU toxicologist: ‘No vape is safe'
PORTSMOUTH, Va. (WAVY) — The trend of vaping use has picked up speed across the United States, particularly among young adults. But as cool as the smoking devices appear, Virginia Commonwealth University Forensic Toxicologist Dr. Michelle Peace says the e-cigarettes are doing more harm than good. Her candid message — no vape is safe. She has discovered in her research that 95% of all compounds in vape products are not safe to inhale. 'The framework exists for protecting the consumer,' Peace said. 'So enforcement really needs to happen full throttle. Probably just as important is education, as misinformation about vaping is rampant.' It's been her mission to expose the hidden toxic chemicals, as most users are in the dark about what they're actually inhaling. 'The primary compounds that make up a vape liquid are propylene glycol and vegetable glycerin,' she said. 'There are compounds such as ethyl acetate that are used as a flavoring chemical.' Ethyl acetate is also used in fingernail polish remover. 'So there are compounds that are used as industrial solvents to clean equipment and brakes, and the food industry uses them as a solvent for flavoring chemicals. That doesn't mean that they're safe to inhale.' So far, the has authorized 39 tobacco and menthol flavored e-cigarette products, though she says there are too many that are unregulated and without quality testing. 'We have found that the products that are authorized by the Food and Drug Administration do have significantly fewer chemicals in them,' she said, 'where, in an unauthorized product, we might find 15 to 20 different chemicals. And then, in an authorized product, we might find five or six. That's significantly less. But nonetheless, there's still chemicals that can harm people and their tissue.' Users can develop a hacking cough, dried out lung tissue or even worse. 'There are some really interesting studies that are coming out that demonstrate that vaping is changing your DNA,' she said. 'There's an indication that maybe your body is 13 years older than a non vapor. Through a project funded by the Virginia Foundation for Healthy Youth, vapes are confiscated on school campuses in the Commonwealth and sent to VCU for testing. For those indirectly inhaling vapes, there's still a second-hand risk. And the bigger issue, according to Peace, is many people are using vapes to consume other drugs. has reported more than 2,800 vaping hospitalizations nationwide. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
Yahoo
3 hours ago
- Yahoo
Perturbed Caitlin Clark fans worry about re-injury over bench behavior
Indiana Fever guard Caitlin Clark is currently not playing basketball, but fans are still concerned. Why? She can't sit down. Clark recently suffered a right groin injury, and after being evaluated by medical staff, she'll remain in recovery and rehabilitation with no time timetable for her return. Her long-term health is the priority, and unfortunately, that means no hoops for now. (Clark will be on the bench for the foreseeable future until she gets better.) In all fairness, asking her not to play basketball is a task in itself. She's one of the most competitive players in the WNBA, and not being on the court is probably one of the hardest things for her to do. That said, it hasn't stopped the second-year guard from being animated on the bench and jumping up and down. Yes, Clark has been quite literally jumping while on the sidelines with a groin injury. It's probably fair to say that she likely can't help herself. (People get hyped about watching sports, and Clark is no different.) The Fever star jumping feels somewhat second nature at this point, but her poor fans are going through it while watching her get active on the Fever's bench. Here's what we mean: Sending positive vibes and thoughts to Fever fans everywhere. To Caitlin Clark, you might want to sit down, friend. You're worrying the people. This article originally appeared on For The Win: Caitlin Clark fans worry about re-injury over behavior on Fever bench
